The future of medtech is being shaped at Innovation Summit Dublin 2025. Join 300+ medtech leaders, investors, and innovators from April 29–May 1 for exclusive insights, strategic networking, and key industry discussions. Don’t miss Europe’s premier medical device partnering event—where the next big breakthroughs happen. Will we see you there? #InnovationDublin25 #medtech #innovation
MedTech Strategist
市场调研
Fairfield,Connecticut 12,378 位关注者
MedTech's Most Trusted Resource. Join us in Dublin, Ireland April 29-May 1, 2025
关于我们
We are MedTech Strategist, MedTech's most trusted resource. We provide professional, premium content for medtech leaders and executives about the challenges, trends, and opportunities in the industry through our medtech industry publications and global medical device investment and networking conferences.
- 网站
-
https://bit.ly/3HFHSVj
MedTech Strategist的外部链接
- 所属行业
- 市场调研
- 规模
- 11-50 人
- 总部
- Fairfield,Connecticut
- 类型
- 私人持股
- 创立
- 2014
- 领域
- Medical Device、Investment Conferences、Medical Technology、Market Analysis、Startups、Market Intelligence、Industry Intelligence、Emerging Companies、Strategy、Publishing、Innovation和MedTech
地点
-
主要
2490 Black Rock Tpke
326
US,Connecticut,Fairfield,06825
MedTech Strategist员工
动态
-
MedTech Strategist is honored to welcome Sigilla Medical alongside CEO Robert Perryman a Presenting Company at the Innovation Summit Dublin 2025. Presenting in the Cardiovascular and Structural Heart Therapeutic Categories, implant free closure of a PFO is the holy grail for patients and cardiologists. Sigilla Medical (Dublin, Ireland) is developing a novel RF energy-based PFO closure system. With no implant the procedure’s risk profile will be improved. Sigilla Medical was founded by NLC Ventures, Robert Perryman and an international medtech company. Successful proof of concept has been completed in a chronic porcine model. The company is now raising €4m to buildout its team and initiate further pre-clinical testing by Dec 2025 Welcome to #InnovationDB25, Sigilla Medical and Robert! #medtech #medicaldevices #cardiovascular #structuralheart #InnovationDublin25
-
We are honored to welcome Lifeblood as a Gold Sponsor for the MedTech Strategist Innovation Summit in Dublin, Ireland April 29-May 1, 2025. Lifeblood is The MedTech Industry's Global Recruitment Firm. They are a team of physicians, engineers, MBAs, PhDs, MedTech investors, board members, and former executives who focus on recruiting talent and organizational consulting for MedTech startups, SMEs, and solution providers. Lifeblood recruits full-scale teams for MedTech companies at all levels from R&D through commercial phases while supporting international MedTech companies in building their US teams as they enter the US market. Their expertise is in recruiting board members, executives, and individual contributors, globally. Thank you Lifeblood for your generous support! #medtech #medicaldevices #medtechrecruitment
-
MedTech Strategist is honored to welcome CorQuest MedTech alongside CEO Olivier Decuypere a Presenting Company at the Innovation Summit Dublin 2025. Presenting in the Cardiovascular Therapeutic Category, MithraX from CorQuest MedTech (Louvain-la-Neuve, Belgium) effectively addresses structural mitral regurgitation (MR) while also preventing functional MR. By preserving the native structures and dynamics of the mitral apparatus, it enhances the expected survival rate. MithraX offers a versatile solution suitable for various patient profiles and types of structural regurgitation. Welcome to #InnovationDB25, CorQuest MedTech and Olivier! #InnovationDublin25 #medtech #cardiovascular #medicaldevices #startups
-
See you all at MedTech Strategist's Innovation Summit in Dublin next month. Make sure to attend our CEO, Enes Ho?g?r, Ph.D.'s panel discussing the future of AI for medical devices, joined by Filip Peters with Acorai, David C. with RebrAIn, Carolina Aguilar with INBRAIN Neuroelectronics and Reed Miller with MedTech Strategist. https://lnkd.in/dpBrPxqR
-
-
Heart disease has been the leading cause of death in the US for the past century, according to a 2024 report from the?American Heart Association. Yet 50-70% of people who suffer a heart attack weren’t being treated appropriately because their risk was unrecognized. Finding those headed toward cardiac danger so they can be treated in time to avoid unwanted consequences is the founding mission of both?Cleerly?and?Bunkerhill Health, which are developing ways of detecting and analyzing an individual’s coronary plaque, so clinicians don’t have to rely solely on surrogates of disease such as blood pressure, elevated cholesterol levels, comorbidities, or family history. Now, a recently announced collaboration between the two companies advances them toward their goal. #medtech #heartdisease #medicaldevices #partnerships
-
-
We are honored to welcome Seroba. as a Platinum Sponsor for the MedTech Strategist Innovation Summit in Dublin, Ireland April 29-May 1, 2025. Seroba. is a European life sciences venture capital firm focused on investing in winning innovations in biotech and medtech.? The team has deep investment and industry experience enabling Seroba to help entrepreneurs realise their ambitions whilst creating value for investors.? The firm has built a strong portfolio of investee companies across multiple indications. Seroba partners with entrepreneurs to create and build businesses around extraordinary science. Thank you Seroba for your generous support! #medtech #medicaldevices #InnovationDublin25 #lifesciences #venturecapital
-
MedTech Strategist is honored to welcome CD Leycom alongside President Patrick Sullivan a Presenting Company at the Innovation Summit Dublin 2025. Presenting in the Diagnostics Therapeutic Category, CD Leycom (Hengelo, The Netherlands) develops medical devices for continuous, real-time assessment of cardiac function. Utilizing proprietary conductance catheterization technology, high-fidelity volume and pressure signals are captured simultaneously enabling direct, real-time ventricular pressure-volume loop monitoring. PV loops are widely recognized as the ‘Gold Standard’ of cardiac performance, providing over 50 quantitative hemodynamic measures related to cardiac energetics, compliance, contractility, and efficiency. Welcome to #InnovationDB25, CD Leycom and Patrick! #medicaldevices #diagnostics #cardiaccare #cardiac
-
We are honored to welcome IQVIA MedTech as aGold Sponsor for the MedTech Strategist Innovation Summit in Dublin, Ireland April 29-May 1, 2025. IQVIA MedTech, part of IQVIA, is a global strategic partner for accelerating MedTech innovation. By intelligently connecting the right insights, technology and MedTech expertise, they help enhance healthcare outcomes of the medical device and in vitro diagnostics industry. Their market leading and specialized solutions and services help boost product strategy with advanced data driven insights, optimize clinical success with accelerated trials and real‐world evidence, streamline efficient pathways for regulatory approvals, ensure compliance with comprehensive cloud‐based solutions and field recall, and maximize business performance with augmented team solutions along the complete product lifecycle. Thank you IQVIA MedTech for your generous support! Many thanks to Ronan McIntyre for your additional kind words. #medtech #medicaldevices #InnovationDublin25 #medtechinnovation
-
We are honored to welcome Addleshaw Goddard as a Platinum Sponsor for the MedTech Strategist Innovation Summit in Dublin, Ireland April 29-May 1, 2025. Addleshaw Goddard LLP is an international law firm with offices in Ireland, the UK, France, Germany, Spain?and The Middle East, providing a comprehensive legal service which is focused on delivering to clients commercial and pragmatic solutions to enable them to run their business more effectively and successfully. They have an expert team of people who have gained wide experience in diverse areas of law. This allows them to offer clients a specifically tailored service to deliver the commercially-focused solutions they require from a legal partner. Thank you Addleshaw Goddard for your generous support! #medtech #medicaldevices #InnovationDublin25